CY1109553T1 - Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv - Google Patents

Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv

Info

Publication number
CY1109553T1
CY1109553T1 CY20091101257T CY091101257T CY1109553T1 CY 1109553 T1 CY1109553 T1 CY 1109553T1 CY 20091101257 T CY20091101257 T CY 20091101257T CY 091101257 T CY091101257 T CY 091101257T CY 1109553 T1 CY1109553 T1 CY 1109553T1
Authority
CY
Cyprus
Prior art keywords
aryl
group
different
alkyl
substituents
Prior art date
Application number
CY20091101257T
Other languages
English (en)
Inventor
Khalid Mekouar
Jean D´ANGELO
Didier Desmaele
Jean-François Mouscadet
Frédéric SUBRA
Christian Auclair
Original Assignee
Centre National De La Recherche Scientifique (Cnrs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National De La Recherche Scientifique (Cnrs) filed Critical Centre National De La Recherche Scientifique (Cnrs)
Publication of CY1109553T1 publication Critical patent/CY1109553T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Τα παράγωγα της κινολεΐνης ανταποκρίνονται στον τύπο (I) στον οποίο: τα Ra, Rb και Rc, όμοια ή διαφορετικά μεταξύ τους, παριστούν έναν ή περισσότερους υποκατάστατες, οι οποίοι κατέχουν μία οποιαδήποτε θέση επί των δακτυλίων, όπου αυτός ή αυτοί οι υποκαταστάτες επιλέγονται μεταξύ μίας ομάδας -(CH2)n-Y ή -CH=CH-Y, όπου το Υ είναι αλογόνο, -OH, -OR, -COH, -COR, COOH, -COOR, -COH, -COR, -CONH2, -CON(Rx, Ry), -CH=NOH, -CO-CH=NOH, -NH2, -N(Rx, Ry), -NΟ2, -PO(OR)2, -SH2,-SR, -SΟ2R, -SO2NHR, -CN ή Z(RC), όπου το R είναι αλκύλιο με 1 έως 8 άτομα άνθρακα, ή αρύλιο ή ετεροκυκλική ομάδα, τα Rx και Ry, όμοια ή διαφορετικά, είναι αλκύλιο με 1 έως 5 άτομα άνθρακα, το Ζ είναι αρύλιο ή ετεροκυκλική ομάδα και το n είναι μηδέν ή ένας ακέραιος με 1 έως 5, ενώ το Rb μπορεί να παριστά εξ άλλου υδρογόνο και όταν το Υ είναι -COOH ή -COOR στο Rc, το Ζ, αν παριστά αρύλιο, περιλαμβάνει τουλάχιστον 3 υποκαταστάτες ή ο πυρήνας κινολεΐνης είναι τρις-υποκατασταθείς, το Χ είναι ένας διπλός αιθυλενικός δεσμός, μία ομάδα -(CH2)n- όπου το n είναι ένας ακέραιος από 1 έως 5 ή μία ομάδα -CH(Rd)-CH(Re)-, όπου τα Rd και Re, όμοια ή διαφορετικά, παριστούν υδρογόνο, αλογόνο, υδροξύλιο ή εποξικό· ή μία ομάδα -(CH2)n’, O-C(O)-O-(CH2)m-, -(CH2)n, C(O)-O-(CH2)m, -(CH2)n, -O-(CH2)m, -(CH2)n, -N(Q)-(CH2)m- ή -(CH2)n, -S(O)t-(CH2)m-, όπου n = 1 έως 8, m = 0 έως 8, t = 0, 1 ή 2 και Q = Η, αρύλιο ή αλκύλιο, καθώς και τα φαρμακευτικά αποδεκτά άλατα αυτών των παραγώγων, οι διαστερεομερείς μορφές τους και οι εναντιομερείς μορφές τους. Εφαρμογή υπό τύπο φαρμάκων με δράση αναστολής της ιντεγράσης του HIV.
CY20091101257T 1997-04-08 2009-12-01 Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv CY1109553T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704289A FR2761687B1 (fr) 1997-04-08 1997-04-08 Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
EP98920581A EP0975597B1 (fr) 1997-04-08 1998-04-07 Derives de quinoleines en tant qu'inhibiteurs de la vih integrase

Publications (1)

Publication Number Publication Date
CY1109553T1 true CY1109553T1 (el) 2014-08-13

Family

ID=9505648

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101257T CY1109553T1 (el) 1997-04-08 2009-12-01 Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv

Country Status (12)

Country Link
US (1) US6670377B1 (el)
EP (1) EP0975597B1 (el)
JP (1) JP4697679B2 (el)
AT (1) ATE441634T1 (el)
CA (1) CA2286385C (el)
CY (1) CY1109553T1 (el)
DE (1) DE69841119D1 (el)
DK (1) DK0975597T3 (el)
ES (1) ES2332434T3 (el)
FR (1) FR2761687B1 (el)
PT (1) PT975597E (el)
WO (1) WO1998045269A1 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321348A1 (en) 2000-09-27 2002-03-27 Blaise Magloire N'zemba Aromatic derivatives with hiv integrase inhibitory properties
FR2819507B1 (fr) * 2001-01-17 2007-09-28 Inst Rech Developpement Ird Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus
EP2033952B1 (en) 2001-03-01 2012-08-29 Shionogi&Co., Ltd. Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity
FR2830863B1 (fr) 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
FR2839646B1 (fr) 2002-05-17 2008-04-11 Bioalliance Pharma Utilisation de derives de quinoleine a effet anti-integrase et ses applications
ATE404537T1 (de) 2002-08-13 2008-08-15 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
BRPI0306214B1 (pt) * 2002-11-20 2017-08-08 Japan Tobacco Inc. 4-oxoquinoline compound and use of this as a hiv integrase inhibitor
KR100866296B1 (ko) * 2004-05-20 2008-11-11 니뽄 다바코 산교 가부시키가이샤 4―옥소퀴놀린 화합물의 안정한 결정체
WO2005113509A1 (en) 2004-05-20 2005-12-01 Japan Tobacco Inc. Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
JP2008542352A (ja) * 2005-06-01 2008-11-27 ビオアリアンス ファルマ キノリン化合物及び他のhiv感染治療薬を含む相乗作用のコンビネーション
IN2014CN00613A (el) 2006-03-06 2015-08-21 Japan Tobacco Inc
WO2008154484A1 (en) * 2007-06-08 2008-12-18 Mannkind Corporation Ire-1a inhibitors
RU2503679C2 (ru) * 2007-11-15 2014-01-10 Джилид Сайенсиз, Инк. Ингибиторы репликации вируса иммунодефицита человека
SI2220076T1 (sl) * 2007-11-15 2012-05-31 Gilead Sciences Inc Inhibitorji replikacije virusa humane imunske pomankljivosti
WO2009062308A1 (en) * 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
EA201200631A1 (ru) * 2007-11-16 2012-11-30 Джилид Сайенсиз, Инк. Ингибиторы репликации вируса иммунодефицита человека
EP2147912A1 (en) 2008-07-23 2010-01-27 BioAlliance Pharma Styrylquinolines, their process of preparation and their therapeutic uses
EP2149557A1 (en) * 2008-07-23 2010-02-03 BioAlliance Pharma Styrylquinolines, their process of preparation and their therapeutic uses
EP2147913A1 (en) 2008-07-23 2010-01-27 BioAlliance Pharma Styrylquinolines, their process of preparation and their therapeutic uses
PE20130525A1 (es) * 2010-07-02 2013-05-05 Gilead Sciences Inc Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih
CA2860015C (en) * 2011-12-22 2020-07-07 Universite Laval Three-dimensional cavities of dendritic cell immunoreceptor (dcir), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (hiv-1)
US20160083343A1 (en) 2013-03-15 2016-03-24 Global Blood Therapeutics, Inc Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
MX2021003158A (es) 2018-09-18 2021-07-16 Nikang Therapeutics Inc Derivados de anillo tricíclico condensado como inhibidores de la fosfatasa de homología a src 2.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152891A (ja) * 1983-02-18 1984-08-31 Yamada Kagaku Kogyo Kk 発色性記録材料
DK282986A (da) * 1985-06-18 1987-02-24 Merck Frosst Canada Inc Substitueret quinolin og farmaceutisk praeparat indeholdende en saadan forbindelse
EP0219307A3 (en) * 1985-10-16 1987-10-14 Merck Frosst Canada Inc. 2-substituted quinolines
JPS61189988A (ja) * 1986-08-11 1986-08-23 Yamada Kagaku Kogyo Kk 発色性記録材料
JPH01199979A (ja) * 1987-04-07 1989-08-11 Kanebo Ltd 新規キノリンカルボン酸誘導体および該化合物を有効成分とする抗菌剤
EP0318093A3 (en) 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylquinoline diacids and their use as medicaments
US5438141A (en) * 1993-05-21 1995-08-01 Merck Frosst Canada, Inc. Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists
EP0643045B1 (de) * 1993-09-10 2000-03-08 Novartis AG Chinolin-Verbindungen als Leukotriene Antagonisten
GB9414590D0 (en) * 1994-07-20 1994-09-07 Leo Pharm Prod Ltd Chemical compounds
ES2103180B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Fenilacetamidas con accion antagonista de los leucotrienos.
EP0725063A1 (de) * 1995-02-01 1996-08-07 Ciba-Geigy Ag Chinolin-Derivate
AU4172197A (en) * 1996-09-10 1998-04-02 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents

Also Published As

Publication number Publication date
CA2286385A1 (fr) 1998-10-15
ES2332434T3 (es) 2010-02-04
FR2761687B1 (fr) 2000-09-15
PT975597E (pt) 2010-01-04
FR2761687A1 (fr) 1998-10-09
JP2001518890A (ja) 2001-10-16
EP0975597B1 (fr) 2009-09-02
US6670377B1 (en) 2003-12-30
JP4697679B2 (ja) 2011-06-08
EP0975597A1 (fr) 2000-02-02
DK0975597T3 (da) 2009-11-02
CA2286385C (fr) 2011-02-01
DE69841119D1 (de) 2009-10-15
WO1998045269A1 (fr) 1998-10-15
ATE441634T1 (de) 2009-09-15

Similar Documents

Publication Publication Date Title
CY1109553T1 (el) Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv
WO2000010965A3 (en) Quaternary ammonium salts and their use as anti-hiv agents
PT87700A (pt) Process for the preparation of a new pyrazolopyridine compound
MX9504349A (es) Derivados de aroilpiperidina.
CA2134359A1 (en) New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
EA200100970A1 (ru) Аминопроизводные как ингибиторы протеазы
DK0620215T3 (da) 1H-indol-3-acetamidderivater som sPLA2-inhibitorer
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
IE831564L (en) N-substituted imidazoles
NO20023995D0 (no) 2-okso-1-pyrrolidinderivater, fremgangsmåte for fremstilling og anvendelse av disse
WO2003068750A1 (fr) Inhibiteur de jnk
EA200600348A1 (ru) Новые соединения
HUP9800295A2 (hu) Szubsztituált heterociklusos vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények, intermedierjeik
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
DK0848004T3 (da) Pyrrolidinderivater med inhiberende aktivitet mod phospholipase A2
RS51047B (sr) Derivati 4-tetrazolil-4-fenilpiperidina za lečenje bola
IL148932A0 (en) INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
DK0916646T3 (da) Fremgangsmåde til fremstillingen af en substitueret 2,5-diamino-3-hydroxyhexan
HUP0101688A2 (hu) Heterociklussal szubsztituált amidok és alkalmazásuk gyógyszerkészítmények előállítására
DE69824450D1 (de) Biphenylamidin-derivate
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
EA200401482A1 (ru) Ненуклезидные ингибиторы обратной транскриптазы
DK0785789T3 (da) Diazepinindoler som phosphodiesterase IV-inhibitorer
DK0701551T3 (da) 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister
YU200791A (sh) Trifluorometil 1-karba (1-detia) cefemi